drugset / Trial / NCT04719793

Umbilical Cord Derived Wharton's Jelly for Knee Osteoarthritis

NCT04719793 ↗

Phase 0 Unknown 12 enrolled BioIntegrate
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and efficacy of intraarticular injection of umbilical cord derived Wharton's Jelly for treatment of knee osteoarthritis symptoms.

Timeline

Start
2023-01-01
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Umbilical Cord-derived Wharton's Jelly Unknown — Other

Indications